Richard Makurumidze

Prof. Richard Makurumidze


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2025 in Global Health Action
Verified
Journal Article
Open access
HMHamufare Dumisani Mugauri
Hamufare Dumisani Mugauri
MCMemory Chimsimbe
Memory Chimsimbe
GSGerald Shambira
Gerald Shambira
SSShepherd Shamhu
Shepherd Shamhu
JNJuliet Nyamasve
Juliet Nyamasve
RMRichard Makurumidze
Richard Makurumidze
Electronic Health Records (EHR) systems offer extensive opportunities to enhance healthcare delivery in sub-Saharan African (SSA) countries by improving data management and patient care and reducing errors. Nonetheless, EHR systems face a myriad of challenges, ranging from infrastructure and resources to policy, data management, and implementers' capacitation. This review provides a comprehensive 10-year overview of EHR implementation in the SSA region. A systematic search of PubMed, Web of Science and HINARI databases identified 30 relevant studies published from 2014 to 2024. Inclusion criteria focused on studies discussing the implementation, benefits, and challenges of EHR systems in SSA countries. Data extraction and thematic analysis facilitated the synthesis of findings. The review identified themes organized into four categories: EHR-enabled data management reduced errors, enhanced accuracy, and improved accessibility of patient records. Improved patient care correlated with better data management, facilitating timely and informed decision-making. Challenges such as limited infrastructure (power and connectivity), financial constraints, data privacy concerns, and the need for extensive training were prevalent. User acceptance also emerged as a critical barrier, with healthcare providers often resistant to adopting innovative technologies due to perceived complexity and the time required for training. EHR systems can significantly enhance healthcare delivery in sub-Saharan Africa. To fully realize these benefits, it is crucial to address challenges through targeted strategies and investments. By investing in reliable infrastructure, securing financial support, enhancing data security, developing comprehensive training programmes, and engaging stakeholders, sub-Saharan Africa can improve data management, patient care, and overall healthcare outcomes.

21 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PMPaddington Tinashe Mundagowa
Paddington Tinashe Mundagowa
STSamantha Nokuthula Tozivepi
Samantha Nokuthula Tozivepi
ECEdward Tafumaneyi Chiyaka
Edward Tafumaneyi Chiyaka
FMFadzai Mukora-Mutseyekwa
Fadzai Mukora-Mutseyekwa
RMRichard Makurumidze
Richard Makurumidze
Background: As a way of minimising the devastating effects of the coronavirus disease 2019 (COVID-19) pandemic, scientists hastily developed a vaccine. However, the scale-up of the vaccine is likely to be hindered by the widespread social media misinformation. We therefore conducted a study to assess the COVID-19 vaccine hesitancy among Zimbabweans. Methods: We conducted a descriptive online cross-sectional survey using a self-administered questionnaire among adults. The questionnaire assessed willingness to be vaccinated; socio-demographic characteristics, individual attitudes and perceptions, effectiveness and safety of the vaccine. Multivariable logistic regression analysis was utilized to examine the independent factors associated with vaccine uptake. Results: We analysed data for 1168 participants, age range of 19–89 years with the majority being females (57.5%). Half (49.9%) of the participants reported that they would accept the COVID-19 vaccine. Majority were uncertain about the effectiveness of the vaccine (76.0%) and its safety (55.0%). About half lacked trust in the government’s ability to ensure availability of an effective vaccine and 61.0% mentioned that they would seek advice from a healthcare worker to vaccinate. Chronic disease [vs no chronic disease—Adjusted Odds Ratio (AOR): 1.50, 95% Confidence Interval (CI)I: 1.10–2.03], males [vs females—AOR: 1.83, 95%CI: 1.37–2.44] and being a healthcare worker [vs not being a health worker—AOR: 1.59, 95%CI: 1.18–2.14] were associated with increased likelihood to vaccinate. Conclusion: We found half of the participants willing to vaccinate against COVID-19. The majority lacked trust in the government and were uncertain about vaccine effectiveness and safety. The policy makers should consider targeting geographical and demographic groups which were unlikely to vaccinate with vaccine information, education and communication to improve uptake.

1 June 2020 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
RMRichard Makurumidze
Richard Makurumidze
Zimbabwe is among the countries that have been identified to be at risk of the COVID-19 pandemic. As of the 15th of March 2020, there was no confirmed case of the virus. Official reports of suspected cases were used to appraise the general screening, case management, and the emergency preparedness and response of the country towards the COVID-19 pandemic. In terms of the surveillance and capacity to screen at the ports of entry, the country seems to be faring well. The country might not be screening optimally, considering the number of COVID-19 tests conducted to date and the suspected cases who missed testing. Three of the suspected cases faced mental, social, and psychological consequences due to them being suspected cases of COVID-19. There is a need to enhance the screening process and infrastructure at all the ports of entry. More COVID-19 diagnostic tests should be procured to increase the testing capacity. Training and awareness on mental, social, and psychological consequences of COVID-19 should be offered to the health care workers and the general public. More financial resources should be sourced to enable the country control the pandemic.

7 January 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRichard Makurumidze
Richard Makurumidze
TMTsitsi Mutasa-Apollo
Tsitsi Mutasa-Apollo
TDTom Decroo
Tom Decroo
RCRegis C Choto
Regis C Choto
KTKudakwashe C Takarinda
Kudakwashe C Takarinda
SRSimbarashe Rusakaniko
Simbarashe Rusakaniko
The last evaluation to assess outcomes for patients receiving antiretroviral therapy (ART) through the Zimbabwe public sector was conducted in 2011, covering the 2007–2010 cohorts. The reported retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. We report findings of a follow-up evaluation for the 2012–2015 cohorts to assess the implementation and impact of recommendations from this prior evaluation. A nationwide retrospective study was conducted in 2016. Multi-stage proportional sampling was used to select health facilities and study participants records. The data extracted from patient manual records included demographic, baseline clinical characteristics and patient outcomes (active on treatment, died, transferred out, stopped ART and lost to follow-up (LTFU)) at 6, 12, 24 and 36 months. The data were analysed using Stata/IC 14.2. Retention was estimated using survival analysis. The predictors associated with attrition were determined using a multivariate Cox regression model. A total of 3,810 participants were recruited in the study. The median age in years was 35 (IQR: 28–42). Overall, retention increased to 92.4% (p-value = 0.060), 86.5% (p-value<0.001), 79.2% (p-value<0.001) and 74.4% (p-value<0.001) at 6, 12, 24 and 36 months respectively. LTFU accounted for 98% of attrition. Being an adolescent or a young adult (15–24 years) (vs adult;1.41; 95% CI:1.14–1.74), children (<15years) (vs adults; aHR 0.64; 95% CI:0.46–0.91), receiving care at primary health care facility (vs central and provincial facility; aHR 1.23; 95% CI:1.01–1.49), having initiated ART between 2014–2015 (vs 2012–2013; aHR1.45; 95%CI:1.24–1.69), having WHO Stage IV (vs Stage I-III; aHR2.06; 95%CI:1.51–2.81) and impaired functional status (vs normal status; aHR1.25; 95%CI:1.04–1.49) predicted attrition. The overall retention was higher in comparison to the previous 2007–2010 evaluation. Further studies to understand why attrition was found to be higher at primary health care facilities are warranted. Implementation of strategies for managing patients with advanced HIV disease, differentiated care for adolescents and young adults and tracking of LTFU clients should be prioritised to further improve retention.

9 July 2022 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
TMTrudy Tholakele Mhlanga
Trudy Tholakele Mhlanga
BJBart K. M. Jacobs
Bart K. M. Jacobs
TDTom Decroo
Tom Decroo
EGEmma Govere
Emma Govere
HBHilda Bara
Hilda Bara
RMRichard Makurumidze
Richard Makurumidze
Background: Since the scale-up of routine viral load (VL) testing started in 2016, there is limited evidence on VL suppression rates under programmatic settings and groups at risk of non-suppression. We conducted a study to estimate VL non-suppression (> 1000 copies/ml) and its risk factors using "routine" and "repeat after enhanced adherence counselling (EAC)" VL results.Methods: We conducted an analytic cross-sectional study using secondary VL testing data collected between 2014 and 2018 from a centrally located laboratory. We analysed data from routine tests and repeat tests after an individual received EAC. Our outcome was viral load non-suppression. Bivariable and multivariable logistic regression was performed to identify factors associated with having VL non-suppression for routine and repeat VL.Results: We analysed 103,609 VL test results (101,725 routine and 1884 repeat test results) collected from the country’s ten provinces. Of the 101,725 routine and 1884 repeat VL tests, 13.8% and 52.9% were non-suppressed, respectively. Only one in seven (1:7) of the non-suppressed routine VL tests had a repeat test after EAC. For routine VL tests; males (vs females, adjusted odds ratio (aOR) = 1.19, [95% CI 1.14–1.24]) and adolescents (10–19 years) (vs adults (25–49 years), aOR = 3.11, [95% CI 2.9–3.31]) were more at risk of VL non-suppression. The patients who received care at the secondary level (vs primary, aOR = 1.21, [95% CI 1.17–1.26]) and tertiary level (vs primary, aOR = 1.63, [95% CI 1.44–1.85]) had a higher risk of VL non-suppression compared to the primary level. Those that started ART in 2014–2015 (vs < 2010, aOR = 0.83, [95% CI 0.79–0.88]) and from 2016 onwards (vs < 2010, aOR = 0.84, [95% CI 0.79–0.89]) had a lower risk of VL non-suppression. For repeat VL tests; young adults (20–24 years) (vs adults (25–49 years), (aOR) = 3.48, [95% CI 2.16 -5.83]), adolescents (10–19 years) (vs adults (25–49 years), aOR = 2.76, [95% CI 2.11–3.72]) and children (0–9 years) (vs adults (25–49 years), aOR = 1.51, [95% CI 1.03–2.22]) were at risk of VL non-suppression.Conclusion: Close to 90% suppression in routine VL shows that Zimbabwe is on track to reach the third UNAIDS target. Strategies to improve the identification of clients with high routine VL results for repeating testing after EAC and ART adherence in subpopulations (men, adolescents and young adolescents) at risk of viral non-suppression should be prioritised.

5 February 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RMRichard Makurumidze
Richard Makurumidze
NGNotion Tafara Gombe
Notion Tafara Gombe
TMTapuwa Magure
Tapuwa Magure
MTMufuta Tshimanga
Mufuta Tshimanga
Background: Anthrax continues to be a disease of public health importance in Zimbabwe, with sporadic outbreaks reported annually in many parts of the country. A human anthrax outbreak occurred in wards 22 and 23 of Makoni District from mid-June 2013 to end of January 2014, following cattle deaths in the wards. Laboratory tests confirmed anthrax as the cause for the cattle deaths. This study investigated the clinical characteristics, distribution of cases (places, person and time) and risk factors for contracting the anthrax disease. We also assessed the environment, district preparedness and response, and outbreak prevention and control measures. Methods: We conducted an outbreak investigation using a mixed-methods design. A 1:1 case-control study was used to assess risk factors for contracting anthrax. The controls were frequency matched to cases by sex. Data were collected using a structured interviewer-administered questionnaire. Environmental assessment, district preparedness and response, and outbreak prevention and control measures were assessed using a checklist, observations, and key informant interviews. Multivariable unconditional logic regression analysis was performed to identify independent risk factors associated with contracting anthrax. Results: We interviewed 37 of the 64 cases, along with 37 controls. All the cases had cutaneous anthrax, with the hand being the most common site of the eschar (43%). Most of the cases (89%) were managed according to the national guidelines. Multivariable analysis demonstrated that meat sourced from other villages [vs butchery, OR = 15.21, 95% CI (2.32–99.81)], skinning [OR = 4.32, 95% CI (1.25–14.94)], and belonging to religions that permit eating meat from cattle killed due to unknown causes or butchered after unobserved death [OR = 6.12, 95% CI (1.28–29.37)] were associated with contracting anthrax. The poor availability of resources in the district caused a delayed response to the outbreak. Conclusion: The described anthrax outbreak was caused due to contact with infected cattle meat. Although the outbreak was eventually controlled through cattle vaccination and health education and awareness campaigns, the response of the district office was initially delayed and insufficient. The district should strengthen its emergency preparedness and response capacity, revive zoonotic committees, conduct awareness campaigns and improve surveillance, especially during outbreak seasons.